Saad, R.S., Silverman, J.F., Khalifa, M.A. and Rowsell, C. (2009) CDX2, Cytokeratins 7 and 20 Immunoreactivity in Rectal Adenocarcinoma. Applied Immunohistochemistry & Molecular Morphology, 17, 196-201.
https://doi.org/10.1097/PAI.0b013e31819268f2

has been cited by the following article:

• TITLE: Colorectal Cancer: Epidemiological Study, Clinical, Histological and Immunohistochemistry Examination in Patient of West Algeria

  AUTHORS: F. Z. Bensaada, H. Ould Cadi, T. Sahraoui, F. Z. El Kebir

  KEYWORDS: Adenocarcinoma, Colorectal Cancer (CRC), Cytokeratin (7, 20)

  JOURNAL NAME: Journal of Cancer Therapy, Vol.8 No.1, January 16, 2017

  ABSTRACT: Colorectal cancer (CRC) is significant publichealth problem in rich countries of the world, because of its frequency and mostly because of its severity. Our aim was to improve histologic diagnosis of malignancy with topographic coloration (HE) and cytokeratins 7, 20 immuno-labeling. The risk for colorectal cancer incease with age, but in our series, 10% of colorectal cancer exist in patients younger than 40 years old. In histological study, adenocarcinoma represented 100% and the evaluation for stage of disease showed that the most dominant isstage IV (32.6%). In our trial, we found that cytokeratins 7 and 20 immunoreactivity in colorectal adenocarcinoma are often positive for cytokeratin-20 and most of time negative for cytokeratin-7.